Syringes of Medigen Vaccine Biologics Corp’s MVC COVID-19 vaccine are pictured in an undated photograph. Photo courtesy of the Food and Drug AdministrationThe Medigen vaccine, the first protein-based COVID-19 vaccine to be made available in Taiwan, would be good for six months before they expire, he added. Medigen secured an emergency use authorization (EUA) for the vaccine from the FDA on July 19. Eligible recipients of the Moderna vaccine in the next round would mainly be people in the ninth priority group of people who have a high-risk disease, a rare disease or catastrophic illness, he added. There are about 880,000 people in the ninth priority group who only selected the Moderna vaccine, Chen said.

Source: Taipei Times August 02, 2021 16:00 UTC